L.V.A.M. Beex

1.1k total citations
33 papers, 844 citations indexed

About

L.V.A.M. Beex is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, L.V.A.M. Beex has authored 33 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in L.V.A.M. Beex's work include Estrogen and related hormone effects (9 papers), Cancer Treatment and Pharmacology (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). L.V.A.M. Beex is often cited by papers focused on Estrogen and related hormone effects (9 papers), Cancer Treatment and Pharmacology (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). L.V.A.M. Beex collaborates with scholars based in Netherlands, Belgium and United Kingdom. L.V.A.M. Beex's co-authors include G.H. Blijham, Hidde M. Kroon, O. L. M. Bijvoet, J. Hermans, F. J. Cleton, J.P. Neijt, H.P. Sleeboom, Socrates E. Papapoulos, André B. P. Kuilenburg and H.I.J. Harinck and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

L.V.A.M. Beex

32 papers receiving 815 citations

Peers

L.V.A.M. Beex
Jamal Zekri Saudi Arabia
A. Galid Austria
D F Hayes United States
A. Robinson United Kingdom
Sara Donati Italy
Grenville Oades United Kingdom
Manuela Motta Italy
C. Parsons United Kingdom
Allan Lipton United States
Jamal Zekri Saudi Arabia
L.V.A.M. Beex
Citations per year, relative to L.V.A.M. Beex L.V.A.M. Beex (= 1×) peers Jamal Zekri

Countries citing papers authored by L.V.A.M. Beex

Since Specialization
Citations

This map shows the geographic impact of L.V.A.M. Beex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.V.A.M. Beex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.V.A.M. Beex more than expected).

Fields of papers citing papers by L.V.A.M. Beex

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.V.A.M. Beex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.V.A.M. Beex. The network helps show where L.V.A.M. Beex may publish in the future.

Co-authorship network of co-authors of L.V.A.M. Beex

This figure shows the co-authorship network connecting the top 25 collaborators of L.V.A.M. Beex. A scholar is included among the top collaborators of L.V.A.M. Beex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.V.A.M. Beex. L.V.A.M. Beex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Span, Paul N., Fred C.G.J. Sweep, L.V.A.M. Beex, & J.A. Foekens. (2005). Mammaglobin remains a useful marker for the detection of breast cancer cells in peripheral blood.. Journal of Clinical Oncology. 23. 3160–3161. 1 indexed citations
3.
Aapro, Matti, F.H. van Wijk, M.E.L. van der Burg, et al.. (2003). Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. European Journal of Cancer. 39(8). 1141–1143. 1 indexed citations
4.
Hamilton, Anne, Laura Biganzoli, Robert E. Coleman, et al.. (2002). EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer. Annals of Oncology. 13(6). 910–918. 83 indexed citations
5.
Ottevanger, P.B., L.V.A.M. Beex, R.P.T.M. Grol, & P.H.M. de Mulder. (1999). Quality of chemotherapy for malignant epithelial ovarian carcinoma in a non trial setting.. European Journal of Cancer. 35. 1 indexed citations
6.
Kuilenburg, André B. P., P. Vreken, L.V.A.M. Beex, Ronney A. De Abreu, & Albert H. Gennip. (1998). Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G -> A point mutation (vol 21, pg 280, 1998). Journal of Inherited Metabolic Disease. 21(7). 1 indexed citations
7.
Kuilenburg, André B. P., P. Vreken, L.V.A.M. Beex, Ronney A. De Abreu, & Albert H. Gennip. (1998). Severe 5‐fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G→A point mutation. Journal of Inherited Metabolic Disease. 21(3). 280–284. 10 indexed citations
8.
9.
Kuilenburg, André B. P., P. Vreken, L.V.A.M. Beex, et al.. (1997). Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. European Journal of Cancer. 33(13). 2258–2264. 90 indexed citations
10.
Beex, L.V.A.M., et al.. (1995). Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Documenta Ophthalmologica. 90(1). 1–6. 50 indexed citations
11.
Kroon, Hidde M., O. L. M. Bijvoet, F. J. Cleton, et al.. (1993). Palliative pamidronate treatment in patients with bone metastases from breast cancer.. Journal of Clinical Oncology. 11(3). 491–498. 164 indexed citations
12.
Kenemans, Peter, Feja J. Voorhorst, L.V.A.M. Beex, et al.. (1993). CA 125 half-life in ovarian cancer: a multivariate survival analysis. British Journal of Cancer. 67(6). 1361–1367. 49 indexed citations
13.
Beex, L.V.A.M., et al.. (1992). Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer. European Journal of Cancer. 28(2-3). 686–690. 9 indexed citations
14.
Wobbes, Th., et al.. (1992). Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. British Journal of Cancer. 65(2). 189–192. 32 indexed citations
15.
16.
Bruning, P.F., Johannes M.G. Bonfrèr, J. Wildiers, et al.. (1990). Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861). The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1013–1019. 1 indexed citations
17.
Hermus, A. R. M. M., L.V.A.M. Beex, G Pieters, et al.. (1988). Hypocalcemia due to osteoblastic metastases and diminished parathyroid reserve in a patient with advanced breast cancer. Journal of Molecular Medicine. 66(14). 643–646. 9 indexed citations
18.
Bijvoet, O. L. M., J. Hermans, H.I.J. Harinck, et al.. (1987). REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT. The Lancet. 330(8566). 983–985. 162 indexed citations
19.
Beex, L.V.A.M., J Burghouts, W.P.M. Breed, et al.. (1987). Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.. PubMed. 71(12). 1151–6. 14 indexed citations
20.
Verheijen, R., L.V.A.M. Beex, D. J. Th. Wagener, & Peter Kenemans. (1985). Cis-platin in combination with low dose adriamycin and cyclophosphamide in advanced ovarian carcinoma.. PubMed. 6(2). 116–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamal Zekri Breakdown of academic impact, for papers by A. Galid Breakdown of academic impact, for papers by D F Hayes Breakdown of academic impact, for papers by A. Robinson Breakdown of academic impact, for papers by Sara Donati Breakdown of academic impact, for papers by Grenville Oades Breakdown of academic impact, for papers by Manuela Motta Breakdown of academic impact, for papers by C. Parsons Breakdown of academic impact, for papers by Allan Lipton
Rankless by CCL
2026